Jaguar Health, Inc.
JAGX
$2.58
$0.010.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -36.91% | 12.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -36.91% | 12.90% | |||
| Cost of Revenue | -7.54% | 2.96% | |||
| Gross Profit | -42.45% | 15.00% | |||
| SG&A Expenses | 12.40% | 13.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.27% | 12.50% | |||
| Operating Income | -15.50% | -12.32% | |||
| Income Before Tax | -3.54% | -2.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.54% | -2.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -57.96% | 88.02% | |||
| Net Income | -5.48% | -0.67% | |||
| EBIT | -15.50% | -12.32% | |||
| EBITDA | -16.45% | -13.13% | |||
| EPS Basic | 19.83% | 20.78% | |||
| Normalized Basic EPS | 18.89% | 21.48% | |||
| EPS Diluted | 19.83% | 20.78% | |||
| Normalized Diluted EPS | 18.89% | 21.48% | |||
| Average Basic Shares Outstanding | 31.56% | 27.08% | |||
| Average Diluted Shares Outstanding | 31.56% | 27.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||